Navigation Links
AcelRx Secures $40 Million Credit Facility with Hercules Technology Growth Capital
Date:12/19/2013

an be drawn at AcelRx's option, at any time between December 15, 2014 and March 15, 2015.  AcelRx plans to use the proceeds of the remaining tranches to provide additional funding for the commercialization of Zalviso and as a potential source of funding for clinical trials for other development programs in its pipeline, and for general corporate purposes.   

General terms of the loan agreement include interest-only payments for 15 months until April 1, 2015, with the possibility of extending the interest-only period to two years until January 1, 2016, if the FDA approves Zalviso on or prior to April 1, 2015.  Following the interest-only period, AcelRx will repay the loans in equal monthly payments of principal and interest through the scheduled maturity date on October 1, 2017 (which would be extended until January 1, 2018 if the Company obtains FDA approval of Zalviso on or prior to April 1, 2015).  Further information with respect to the loan arrangement with Hercules, is contained in a Current Report on Form 8-K to be filed on December 19, 2013 by AcelRx with the Securities and Exchange Commission.

About AcelRx Pharmaceuticals, Inc.

AcelRx Pharmaceuticals, Inc. is a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of acute and breakthrough pain. AcelRx's lead product candidate, Zalviso™, is designed to solve the problems associated with post-operative intravenous patient-controlled analgesia which has been shown to cause harm to patients following surgery because of the side effects of morphine, the invasive IV route of delivery and the complexity of infusion pumps. AcelRx has announced positive results from each of the three completed Phase 3 clinical trials for Zalviso, and has submitted an NDA to the FDA seeking approval for Zalviso in the treatment of moderate-to-severe acute pain in adult patients in the hospital setting. 
'/>"/>

SOURCE AcelRx Pharmaceuticals, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. AcelRx Pharmaceuticals Presents ARX-04 Dose-Finding Phase 2 Study Data at Anesthesia Medical Conference
2. AcelRx Pharmaceuticals Adds New Board Member
3. Annual General Meeting Schedules, New Drug Applications, Positive Study Results, Conference Participations, and Secondary Offerings - Research Report on Mindray, AcelRx, Merrimack, ZELTIQ, and Clovis
4. AcelRx Pharmaceuticals to Present at the 25th Annual Piper Jaffray Healthcare Conference
5. AcelRx Pharmaceuticals Reports Third Quarter 2013 Financial Results
6. AcelRx Pharmaceuticals to Hold Third Quarter 2013 Financial Results Conference Call and Webcast on November 5, 2013
7. David H. Chung Joins AcelRx Pharmaceuticals as Chief Commercial Officer
8. AcelRx Pharmaceuticals to Present at the Stifel Healthcare Conference 2013
9. AcelRx Pharmaceuticals Reports Second Quarter 2013 Financial Results
10. AcelRx Pharmaceuticals to Present at Canaccord Genuity 33rd Annual Growth Conference
11. AcelRx Pharmaceuticals to Hold Second Quarter 2013 Financial Results Conference Call and Webcast on August 12, 2013
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/29/2014)... DUBLIN , Aug. 29, 2014 ... the "Global Multiple Sclerosis Drugs Market 2014-2018" ... is a chronic, inflammatory medical condition that results in ... damaged because of an abnormal response by the immune ... (CNS). It is a potentially debilitating disease in which ...
(Date:8/29/2014)...  Abaxis, Inc. (NasdaqGS: ABAX ), a ... to the medical, research and veterinary markets, announced today ... Officer, will present at the CL King 12 th ... 9, 2014 at 12:30 p.m. ET. The conference will ... New York City . ...
(Date:8/29/2014)... and MENLO PARK, Calif. ... Pharmaceuticals, Inc. (OTCQB: DMPI) ("DelMar" "the Company") today ... financial statements.  The Company recently changed its fiscal year ... application to list its common stock on a national ... DelMar,s financial statements as filed with the United States ...
Breaking Medicine Technology:Global Multiple Sclerosis Drugs Market 2014-2018: Key Vendors are Bayer, Biogen Idec, Merck Serono, Novartis and Teva Pharmaceutical 2Global Multiple Sclerosis Drugs Market 2014-2018: Key Vendors are Bayer, Biogen Idec, Merck Serono, Novartis and Teva Pharmaceutical 3Abaxis, Inc. to Present at CL King's 12th Annual Best Ideas Conference 2014 2DelMar Pharmaceuticals Fiscal 2014 Year End Results and Summary of Recent Developments 2DelMar Pharmaceuticals Fiscal 2014 Year End Results and Summary of Recent Developments 3DelMar Pharmaceuticals Fiscal 2014 Year End Results and Summary of Recent Developments 4DelMar Pharmaceuticals Fiscal 2014 Year End Results and Summary of Recent Developments 5
... 5, 2011 Ridge Diagnostics, Inc., a neurodiagnostic ... the 6th Annual Neurotech Investing and Partnering Conference to be ... on May 9th and 10th.   Ms. Williams, ... entitled "Next Generation Psychiatry" lead by Dr. Manuel Lopez-Figueroa, Vice ...
... Taking the right dose is vital to ensuring that ... any harm. (Logo:   http://photos.prnewswire.com/prnh/20090824/FDALOGO ) ... droppers, or syringes designed to measure the proper dose. But ... there have been accidental overdoses. Find out how ...
Cached Medicine Technology:Ridge Diagnostics, Inc. CEO to Speak at Neurotech Investing and Partnering Conference 2
(Date:8/30/2014)... Market Research Report on Global and ... and in-depth market survey on Global and Chinese ... basic information of Lab Oven including its classification, ... global and China’s top manufacturers of Lab Oven ... market share etc. , The report further analyzes ...
(Date:8/30/2014)... (PRWEB) August 30, 2014 Serving contented ... in India, Profit By Outsourcing is now offering ... services. The company gives emphasize on putting forward the ... product to clients. Their dedicated team of professionals and ... results. They can handle even the critical issues of ...
(Date:8/30/2014)... New York, New York (PRWEB) August 30, 2014 ... consolidated litigation for transvaginal mesh lawsuits ( http://www.injurybeacon.com/transvaginal-mesh/ ... the company’s request to sever four cases selected ... to an Order issued on August 18, 2014, ... Southern District of West Virginia disagrees with Boston ...
(Date:8/30/2014)... Saturday 30 August 2014: Transvenous lead extraction (TLE) is ... to data from the European Lead Extraction ConTRolled (ELECTRa) ... Congress 2014 by Dr Maria Grazia Bongiorni, chair of ... number of cardiac implantable electronic devices (CIED) implant procedures ... the number of complications has increased and leads are ...
(Date:8/30/2014)... 30, 2014 In today’s world, a ... difficult to get. Snoring and sleep apnea (a medical ... stops) robs people and their bed partners of the ... to 45% of the population snores and 20 million ... Of these, only 10% have been diagnosed and treated; ...
Breaking Medicine News(10 mins):Health News:Lab Oven Industry for Global and Chinese Market Forecasts to 2019 in New Research Report Available at ReportsnReports.com 2Health News:Lab Oven Industry for Global and Chinese Market Forecasts to 2019 in New Research Report Available at ReportsnReports.com 3Health News:Lab Oven Industry for Global and Chinese Market Forecasts to 2019 in New Research Report Available at ReportsnReports.com 4Health News:Profit By Outsourcing Offering Discount for Labor Day on all Web Development Services 2Health News:Transvaginal Mesh Lawsuit News: Federal Judge Refuses Boston Scientific Request for Separate Trials in Four Bellwether Cases, Bernstein Liebhard LLP Reports 2Health News:Transvaginal Mesh Lawsuit News: Federal Judge Refuses Boston Scientific Request for Separate Trials in Four Bellwether Cases, Bernstein Liebhard LLP Reports 3Health News:Transvenous lead extraction clinically successful in 98 percent of cases 2Health News:Transvenous lead extraction clinically successful in 98 percent of cases 3Health News:Snoring: Bad for Relationships, Bad for Health 2Health News:Snoring: Bad for Relationships, Bad for Health 3
... Spanish Wine Fair (Fenavin) here, India has said it ... in production if a strong element of "price sensitivity" ... necessarily mean selling the cheapest wine," Subhash Arora, president ... three-day fair Wednesday. ,India already has a ...
... agreed to import eggs, fish, fruits, vegetables and other ... Minister Y.S. Rajasekhara Reddy, who is currently visiting Singapore, ... Chuasin Bin, CEO of agri food veterinary authority, government ... the chief minister's office here, he suggested to Singapore ...
... Canadian researchers are beginning to realize that childhood cholesterol ... and could be hence used as an invaluable ... Ian Janssen, assistant professor in the School of Kinesiology ... conducted a study into the subject: There is ...
... tainted ground beef bought from stores caused E.Coli outbreak. Seven ... before they recovered. Severe stomach cramps and diarrhea are ... meat company believed to be responsible for supplying tainted stuff, ... eight states. ,The US Department of Agriculture confirmed ...
... evidence that patients with chronic neck pain enrolled ... spinal manipulation, according to a report in ... ,According to Howard Vernon, DC, ... the literature review confirm the common clinical experience ...
... Intake of fruit juice does not cause obesity in children, ... college . ,The researchers during the survey studied ... of 2-11 years. ,"We did not find a ... said Theresa Nicklas, a child nutrition researcher at the Baylor ...
Cached Medicine News:Health News:India is Uncorking Its Wine Market: Expert 2Health News:Scientists Recommend New Guidelines For Cholesterol Testing In Children 2Health News:Beef Firm in US Withdraws Its Products from Markets After E. Coli Outbreak. 2Health News:Spinal Manipulation Beneficial for Neck Pain 2
This compact, easy-to-operate analyzer delivers basic blood gas, ISEs with direct measured total hemoglobin and saturated oxygen. Use it as a cost effective backup for the central lab or for remote p...
... performance and rapid, small volume sample ... rotor. DiscoveryTMM120 SE processes sample sizes ... with a small floor footprint, brushless ... imbalance detection, thermo-electric cooling, and automatic ...
... Efficiency, versatility, and environmental ... the Optima LE-80 K Ultracentrifuge ... Coulters innovative Optima centrifugation technology, ... to cost effectively provide advanced ...
... small-volume samples. With the ability to provide ... (fat particles in lipemic samples), the Airfuge ... Lipemic samples can be cleaned in 10 ... The easy-to-operate tabletop centrifuge: Reaches top speed ...
Medicine Products: